Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dermal Interstitial Glycogenosis and Stromal Senescence-Associated Marker Expression in Fibrofolliculomas: Implications for Pathogenesis and mTOR-Targeted Therapy.

The American Journal of dermatopathology·2026
Same author

Coexistence of cicatricial alopecia and alopecia areata: A case series.

JAAD case reports·2026
Same author

Enfortumab vedotin-induced cutaneous toxicities and their association with survival in urothelial carcinoma.

medRxiv : the preprint server for health sciences·2026
Same author

Systematic "Head-to-Head" Comparison of Scalp Biopsy Techniques for Alopecia Diagnosis: Diagnostic Adequacy, Efficiency, and Resource Utilization.

Journal of cutaneous pathology·2026
Same author

The impact of next generation sequencing studies on the diagnosis of BAP1 inactivated melanocytic tumors.

Human pathology·2026
Same author

Wound Management and Surgery for Calcific Uremic Arteriolopathy (Calciphylaxis): A Retrospective Observational Cohort Study.

International wound journal·2026

Related Experiment Video

Updated: Jun 21, 2026

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
07:22

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis

Published on: March 14, 2025

Warfarin-induced skin necrosis.

Rosalynn M Nazarian1, Elizabeth M Van Cott, Artur Zembowicz

  • 1Department of Pathology and Dermatopathology Unit, Harvard Medical School and Massachusetts General Hospital, Boston, Massachusetts 02114, USA.

Journal of the American Academy of Dermatology
|July 21, 2009
PubMed
Summary
This summary is machine-generated.

Warfarin-induced skin necrosis is a rare but serious complication of anticoagulant therapy. Prompt diagnosis through clinical and histological evaluation is crucial for effective patient management.

Related Experiment Videos

Last Updated: Jun 21, 2026

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
07:22

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis

Published on: March 14, 2025

Area of Science:

  • Dermatology
  • Hematology
  • Pathology

Background:

  • Warfarin is a widely used anticoagulant medication.
  • Skin necrosis is a rare but severe adverse effect of warfarin therapy.
  • Early recognition and cessation of warfarin are critical to minimize morbidity and mortality.

Observation:

  • Cutaneous manifestations include petechiae, ecchymoses, and hemorrhagic bullae.
  • Dermatopathology reveals dermal microthrombi, endothelial damage, and red cell extravasation.
  • Progression leads to full-thickness coagulative necrosis of the skin.

Findings:

  • Distinguishing warfarin-induced skin necrosis from other conditions can be challenging.
  • Skin biopsy is essential for diagnosis, alongside clinical history and laboratory data.
  • Key diagnostic factors include lesion onset, distribution, and histological findings.

Implications:

  • Accurate differentiation is vital for appropriate patient treatment and management.
  • Understanding the clinical and histological features aids in prompt diagnosis.
  • This review highlights the diagnostic difficulties and emphasizes a multidisciplinary approach.